Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Exclusion Criteria

• •Patients will not be eligible for this study if they:
• •Have had severe diarrhea within 30 days of study entry.
• •Have a history of pancreatic disease or any other serious condition.
• •Have hepatitis within 30 days of study entry.
• •Are diagnosed with an opportunistic (AIDS-related) infection at the time of enrollment.
• •Are unable to take medications by mouth.
• •Have received certain medications.
• •Are pregnant or breast-feeding.